About Us

Two Additional Appeals Rejected in Disease Team Round

Posted: September 9, 2012 at 3:50 pm

The governing board of the California stem cell agency last night rejected appeals by two applicants -- OncoMed Pharmaceuticals of Redwood City and Albert Wong of Stanford -- in the $200 million disease team round.

Both petitions generated little discussion. You can find more on their petitions here and here.

The board also approved changes in its intellectual property and grant administration rules. Both proposals will now enter the state's official administrative law process for more comment and possible change.


Related Post

No Comments

No comments yet.

Sorry, the comment form is closed at this time.